Form 4 for ABBV AbbVie
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001415889-23-003856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-03-01 | ABBV | Sorg Elaine K. | SVP, US COMMERCIAL Ops | M - OptEx | $93.50 | +15.0K | 57.8K | +35% | +$1.40M |
| D | 2023-03-02 | 2023-02-28 | ABBV | Sorg Elaine K. | SVP, US COMMERCIAL Ops | F - Tax | $154.28 | -19.9K | 42.8K | -32% | -$3.06M |
| D | 2023-03-02 | 2023-03-01 | ABBV | Sorg Elaine K. | SVP, US COMMERCIAL Ops | S - Sale+OE | $155.00 | -15.0K | 42.8K | -26% | -$2.33M |
| D | 2023-03-02 | 2023-03-01 | ABBV | Sorg Elaine K. | SVP, US COMMERCIAL Ops | M - OptEx | $93.50 | -15.0K | 0 | -100% | -$1.40M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2023-03-01 | M | A | 15,003 | $93.50 | 57,832 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2023-02-28 | F | D | 19,850 | $154.28 | 42,829 | D | — | — | |
| 3 | Common | Common Stock, $0.01 par value | 2023-03-01 | S | D | 15,003 | $155.00 | 42,829 | D | — | — | |
| 4 | Derivative | Option (Right to Buy) | 2023-03-01 | M | D | 15,003 | $93.50 | 0 | D | $93.50 · 2020-02-20 to 2030-02-19 | 15,003 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |